Bradford C. Dickerson, MD, is an associate professor of neurology at Harvard Medical School, and the Tom Rickles Endowed Chair in aphasia research at Massachusetts General Hospital, both in Boston. He is a behavioral neurologist and cognitive neuroscientist and uses neuroimaging to study brain anatomy, function, and molecular composition in aging and neurodegenerative diseases.
Dickerson is also the director of the frontotemporal disorders unit, the director of clinical applications in the morphometry service, a co-director of the gerontology research unit's neuroimaging group, and a co-investigator in the imaging core of the Alzheimer's Disease Research Center, all at Massachusetts General Hospital.
Ruben Kuzniecky, MD, is a professor of neurology at New York University School of Medicine, a co-director of the NYU Comprehensive Epilepsy Center, and director of epilepsy research at NYU Langone Medical Center, all in New York City.
Kuzniecky is also a co-principal investigator on the Epilepsy Phenome Genome Project, and a co-principal investigator on the Human Epilepsy Project.
Benjamin Walter, MD, is an assistant professor of neurology at Case Western Reserve University School of Medicine, the medical director of the Deep Brain Stimulation Program at UH Case Medical Center, and director of the Movement Disorder Center at University Hospitals, all in Cleveland, Ohio.
Albert S. Favate, MD, is an assistant professor of neurology at New York University School of Medicine and the division chief of the vascular neurology department and Stroke Care Center at NYU Langone Medical Center in New York City.
Neurology Advisor Articles
- Brainstem Damage in Epilepsy May Be Biomarker for Increased SUDEP Risk
- Increased Epilepsy Risk Identified in Multiple Sclerosis
- Distinct Clinical Characteristics Associated With Subarachnoid Hemorrhage
- Managing Chronic Pain Associated With Traumatic Brain Injury
- Prognostic Significance of Weight Loss in Patients With Early Parkinsonism
- Coffee Consumption May Decrease Stroke Risk
- When and How to Approach Driving Cessation in Patients With Dementia
- NBT System Gets FDA Clearance for Depression Treatment
- Erenumab, Fremanezumab Reduce Migraine Frequency, Burden
- Some Antiepileptic Drugs Associated With Increased Risk for Toxic Epidermal Necrolysis
- McDonald Criteria Update: Further Distinction Between Relapsing-Remitting, Primary-Progressive MS
- Initial Treatment With Ethosuximide Improves Behavioral Outcomes in Childhood Absence Epilepsy
- Bivacizumab Wins Full FDA Approval for Glioblastoma Treatment
- Men With Parkinson Disease More Likely to Have Caregiver
- Diet Linked to Multiple Sclerosis Disability, Diseases Severity